A unique case of indolent microscopic polyangiitis in an elderly gentleman: a case report and brief review
Abstract
##plugins.themes.bootstrap3.article.details##
Vasculitis, Antineutrophil cytoplasmic autoantibody, ANCA associated vasculitis, Microscopic polyangiitis, Indolent vasculitis, Granulomatosis with polyangiitis, Eosinophilic granulomatosis and polyangiitis, Renal biopsy
2. Yates M, Watts R. ANCA-associated vasculitis. Clin Med (Lond). 2017;17(1):60-64. doi: 10.7861/clinmedicine.17-1-60. PMID: 28148583; PMCID: PMC6297586.
3. Hashmi MF, Jain V, Tiwari V. Microscopic Polyangiitis. StatPearls. Treasure Island (FL): StatPearls Publishing. 2023, StatPearls Publishing LLC.; 2023.
4. Gagnier JJ, Kienle G, Altman DG, et al. The CARE Guidelines: Consensus-based Clinical Case Reporting Guideline Development. Glob Adv Health Med. 2013;2(5):38-43. doi: 10.7453/gahmj.2013.008. PMID: 24416692; PMCID: PMC3833570.
5. Suppiah R, Robson JC, Grayson PC, et al. 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for microscopic polyangiitis. Ann Rheum Dis. 2022;81(3):321-326. doi: 10.1136/annrheumdis-2021-221796. PMID: 35110332.
6. Gatenby PA. Unusually indolent MPO-ANCA: associated vasculitis-report of two cases. CEN Case Rep. 2013;2(2):131-133. doi: 10.1007/s13730-012-0045-y. PMID: 28509287; PMCID: PMC5413649.
7. Hauer HA, Bajema IM, van Houwelingen HC, et al. Renal histology in ANCA-associated vasculitis: differences between diagnostic and serologic subgroups. Kidney Int. 2002;61(1):80-9. doi: 10.1046/j.1523-1755.2002.00089.x. PMID: 11786087.
8. Bajema IM, Hagen EC, Hermans J, et al. Kidney biopsy as a predictor for renal outcome in ANCA-associated necrotizing glomerulonephritis. Kidney Int. 1999;56(5):1751-8. doi: 10.1046/j.1523-1755.1999.00758.x. PMID: 10571783.
9. Franssen C, Gans R, Kallenberg C, Hageluken C, Hoorntje S. Disease spectrum of patients with antineutrophil cytoplasmic autoantibodies of defined specificity: distinct differences between patients with anti-proteinase 3 and anti-myeloperoxidase autoantibodies. J Intern Med. 1998;244(3):209-16. doi: 10.1046/j.1365-2796.1998.00357.x. PMID: 9747743.
10. Smyth L. ANCA-associated vasculitis Australian Clinical Labs: Australian Clinical Labs Media Releases; 2016 [https://www.clinicallabs.com.au/about-us/doctor-media-releases/anca-associated-vasculitis/ available at 12/13/2023]
11. Drooger JC, Dees A, Swaak AJ. ANCA-Positive Patients: The Influence of PR3 and MPO Antibodies on Survival Rate and The Association with Clinical and Laboratory Characteristics. Open Rheumatol J. 2009;3:14-7. doi: 10.2174/1874312900903010014. PMID: 19461938; PMCID: PMC2684710.
12. Watts RA, Hatemi G, Burns JC, Mohammad AJ. Global epidemiology of vasculitis. Nat Rev Rheumatol. 2022;18(1):22-34. doi: 10.1038/s41584-021-00718-8. PMID: 34853411; PMCID: PMC8633913.
13. Lionaki S, Blyth ER, Hogan SL, et al. Classification of antineutrophil cytoplasmic autoantibody vasculitides: the role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis. Arthritis Rheum. 2012;64(10):3452-62. doi: 10.1002/art.34562. PMID: 23023777; PMCID: PMC3462364.
14. Redondo-Rodriguez R, Mena-Vázquez N, Cabezas-Lucena AM, et al. Systematic Review and Metaanalysis of Worldwide Incidence and Prevalence of Antineutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis. J Clin Med. 2022;11(9):2573. doi: 10.3390/jcm11092573. PMID: 35566698; PMCID: PMC9106044.
15. Almaani S, Fussner LA, Brodsky S, Meara AS, Jayne D. ANCA-Associated Vasculitis: An Update. J Clin Med. 2021;10(7):1446. doi: 10.3390/jcm10071446. PMID: 33916214; PMCID: PMC8037363.
16. Comarmond C, Crestani B, Tazi A, et al. Pulmonary fibrosis in antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis: a series of 49 patients and review of the literature. Medicine (Baltimore). 2014;93(24):340-349. doi: 10.1097/MD.0000000000000217. Erratum in: Medicine (Baltimore). 2014;93(24):414. Erratum in: Medicine (Baltimore). 2015;94(2):1. PMID: 25500703; PMCID: PMC4602438.
17. Ando M, Miyazaki E, Ishii T, et al. Incidence of myeloperoxidase anti-neutrophil cytoplasmic antibody positivity and microscopic polyangitis in the course of idiopathic pulmonary fibrosis. Respir Med. 2013;107(4):608-15. doi: 10.1016/j.rmed.2013.01.006. PMID: 23434037.
Archive of Clinical Cases is protected by copyright and may be used in accordance with copyright and other applicable laws. Content available at www.clinicalcases.eu and our digital applications is intended for personal noncommercial use.
Authors who submit a manuscript for publication in Archive of Clinical Cases agree to the following terms: a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) only after the final version of the manuscript was accepted and published, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access). d. It is compulsory that before submission authors ensure that their work was not published in any other medical journals or pending acceptance for publication and that "Archives of Clinical Cases" is the only beneficiary at that moment if their work/case will be accepted by us.
Guidelines for linking to www.clinicalcases.eu a. The main purpose of the site linking to the Archive of Clinical Casess site should be educational. b. Links should be made to the Archive of Clinical Casess home page (www.clinicalcases.eu) or to the articles abstract. c. It is forbidden to use the Archive of Clinical Casess cover by outside organizations unless permission has been granted in advance, notifying our Secretary. d. Material owned by the Archive of Clinical Cases (including the name, logo, cover, and text) may not be used in any manner that may induce the idea or suggest that the Archive of Clinical Cases is in some way recommending a specific company, product or service. e. You must not use or allow others to access or use, all or any part of our Site or the contents and/or applications on it for commercial purposes without our permission. To seek permission to do anything prohibited by or not contained in these TERMS, or which requires our prior consent or agreement, you can contact us.